OMESAR

This brand name is authorized in Ireland, Malta, South Africa

Active ingredients

The drug OMESAR contains one active pharmaceutical ingredient (API):

1 Olmesartan medoxomil UNII 6M97XTV3HD - OLMESARTAN MEDOXOMIL

Olmesartan medoxomil is a potent, orally active, selective angiotensin II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin II. The selective antagonism of the angiotensin II (AT1) receptors results in increases in plasma renin levels and angiotensin I and II concentrations, and some decrease in plasma aldosterone concentrations. Read about Olmesartan medoxomil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OMESAR Film-coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09CA08	Olmesartan medoxomil	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: IE	Health Products Regulatory Authority	Identifier(s): 21493, 37602, 37617, 37620, 37628, 37631, 40751, 40852, 41857, 41978
Country: MT	Medicines Authority	Identifier(s): MA204/00301, MA204/00302, MA204/00303
Country: ZA	Health Products Regulatory Authority	Identifier(s): 40/7.1.3/0406.403, 40/7.1.3/0407.404, 40/7.1.3/0408.405